Read + Share
Amedeo Smart
Independent Medical Education
Halbherr S, Lerch S, Bellwald S, Polakova P, et al. Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial). PLoS Med 2025;22:e1004472.PMID: 40359409
Email
LinkedIn
Privacy Policy